Nationwide analysis observes declining radioiodine use in differentiated thyroid carcinoma, suggesting improved treatment strategies.
Brazilian medical practice has increasingly aligned with international DTC guidelines, showing a decline in RAI use and a shift toward low-to-high RAI activities. This suggests broader adoption of risk-adapted strategies. Notwithstanding, high-dose RAI still predominates, pointing that dissemination of standardized treatment protocols could further enhance DTC care within the Brazilian health system.
No takes yet. Share an insight, caveat, or question.
Dora et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: